arrow
S

Sean K. Bedingfield

eli lilly & company
H指数:9
被引数:536

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
2023-05-0113
OAAI
Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction

调节配体密度以优化靶向纳米颗粒的药代动力学,以双重保护抗肿瘤诱导的骨破坏

2020-01-0254
OAAI